These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19809337)

  • 61. Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.
    Rustembegovic A; Sofic E; Wichart I
    Med Arh; 2006; 60(4):211-2. PubMed ID: 16761509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The influence of side effect of antipsychotic on the course of treatment in adolescent.
    Graovac M; Ruzić K; Rebić J; Dadić-Hero E; Francisković T
    Psychiatr Danub; 2010 Mar; 22(1):108-11. PubMed ID: 20305603
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.
    Hellings JA; Zarcone JR; Valdovinos MG; Reese RM; Gaughan E; Schroeder SR
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):885-92. PubMed ID: 16379508
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea.
    Takahashi H; Higuchi H; Kamata M; Naitoh S; Yoshida K; Shimizu T; Sugita T
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):375-7. PubMed ID: 12928517
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of quetiapine in children and adolescents.
    Masi G; Milone A; Veltri S; Iuliano R; Pfanner C; Pisano S
    Paediatr Drugs; 2015 Apr; 17(2):125-40. PubMed ID: 25686575
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperprolactinemia in an adolescent with psychotic disorder on risperidone.
    Jummani R; Coffey BJ
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):791-4. PubMed ID: 20035598
    [No Abstract]   [Full Text] [Related]  

  • 67. Hyperprolactinaemia during treatment with paliperidone.
    Skopek M; Manoj P
    Australas Psychiatry; 2010 Jun; 18(3):261-3. PubMed ID: 20429680
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.
    Copur M; Arpaci B; Demir T; Narin H
    Clin Drug Investig; 2007; 27(2):123-30. PubMed ID: 17217317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Switching elderly patients with dementia from risperidone to quetiapine: a retrospective study.
    Madhusoodanan S; Bogunovic O
    Am J Alzheimers Dis Other Demen; 2006; 21(3):169-74. PubMed ID: 16869337
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Randomized controlled trial comparing changes in serum prolactin and weight among female patients with first-episode schizophrenia over 12 months of treatment with risperidone or quetiapine.
    Liu J; Sun J; Shen X; Guo W; Zhi S; Song G; Xu Q; Song J
    Shanghai Arch Psychiatry; 2014 Apr; 26(2):88-94. PubMed ID: 25092954
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Open-label quetiapine in the treatment of children and adolescents with autistic disorder.
    Martin A; Koenig K; Scahill L; Bregman J
    J Child Adolesc Psychopharmacol; 1999; 9(2):99-107. PubMed ID: 10461820
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures.
    McAdam DB; Zarcone JR; Hellings J; Napolitano DA; Schroeder SR
    Am J Ment Retard; 2002 Jul; 107(4):261-9. PubMed ID: 12069645
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Update and recommendations for the use of antipsychotics in early-onset psychoses.
    Bryden KE; Carrey NJ; Kutcher SP
    J Child Adolesc Psychopharmacol; 2001; 11(2):113-30. PubMed ID: 11436951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting.
    Currier GW; Trenton AJ; Walsh PG; van Wijngaarden E
    J Psychiatr Pract; 2006 Jul; 12(4):223-8. PubMed ID: 16883147
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High dose quetiapine in the treatment of psychosis due to traumatic brain injury: a case report.
    Trémeau F; Mauro CJ; Shope C; Riber LM; Dhami S; Citrome L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):280-1. PubMed ID: 20854867
    [No Abstract]   [Full Text] [Related]  

  • 78. Quetiapine and leukopenia.
    Clark N; Weissberg E; Noel J
    Am J Psychiatry; 2001 May; 158(5):817-8. PubMed ID: 11329413
    [No Abstract]   [Full Text] [Related]  

  • 79. Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects.
    dos Santos Júnior A; Henriques TB; de Mello MP; Ferreira Neto AP; Paes LA; Della Torre OH; Sewaybricker LE; Fontana TS; Celeri EH; Guerra Júnior G; Dalgalarrondo P
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):738-48. PubMed ID: 26682995
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.
    Buitelaar JK
    J Child Adolesc Psychopharmacol; 2000; 10(1):19-26. PubMed ID: 10755578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.